Simponi 50 mg solution for injection in pre-filled syringe. clinical trials

A Phase 3 Randomized, Open-Label Study to Assess the Efficacy, Safety, and Pharmacokinetics of Golimumab Treatment, a Human anti-TNFα Monoclonal Antibody, Administered Subcutaneously in Pediatric Participants with Moderately to Severely Active Ulcerative Colitis

This study is looking at a medicine called Simponi for children and teenagers with a gut condition called ulcerative colitis. It wants to see if Simponi can help them feel better and heal their gut, and if it's safe to use.